John D. Davis
0000-0001-6282-1670
Publication & Citation Trends
Publications
0 total
Target‐Mediated Modeling of Alirocumab in Adolescents and Children ≥8 to <12 Years of Age Using Phase II and III Data
Cited by 0
Semantic Scholar
Comparison of Model‐Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial Hypercholesterolemia OA
Cited by 3
Semantic Scholar
Population Pharmacokinetics and Exposure‐Response Modeling for Evinacumab in Children, Adolescents, and Adults With Homozygous Familial Hypercholesterolemia OA
Cited by 3
Semantic Scholar
Population Pharmacokinetics of Fasinumab in Healthy Volunteers and Patients With Pain Due to Osteoarthritis of the Knee or Hip OA
Cited by 1
Semantic Scholar
Garetosmab in Fibrodysplasia Ossificans Progressiva: Clinical Pharmacology Results from the Phase 2 LUMINA‐1 Trial OA
Cited by 3
Semantic Scholar
Research Topics
Biochemical Analysis and Sensing Techniques
(29)
Regulation of Appetite and Obesity
(27)
Dermatology and Skin Diseases
(25)
Asthma and respiratory diseases
(23)
Allergic Rhinitis and Sensitization
(22)
Affiliations
Hospital for Special Surgery
American Dental Association
Pennsylvania State University
Amgen (United States)
United States Department of Veterans Affairs